Micro-costing analysis of guideline-based treatment by direct-acting agents: the real-life case of hepatitis C management in Brazil

BACKGROUND: Eradication of hepatitis C virus (HCV) using direct-acting agents (DAA) has been associated with a financial burden to health authorities worldwide. We aimed to evaluate the guideline-based treatment costs by DAAs from the perspective of the Brazilian Ministry of Health (BMoH). METHODS:...

Descripción completa

Detalles Bibliográficos
Autores principales: Perazzo, Hugo, Jorge, Marcelino Jose, Silva, Julio Castro, Avellar, Alexandre Monken, Silva, Patrícia Santos, Romero, Carmen, Veloso, Valdilea Gonçalves, Mujica-Mota, Ruben, Anderson, Rob, Hyde, Chris, Castro, Rodolfo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5701370/
https://www.ncbi.nlm.nih.gov/pubmed/29169329
http://dx.doi.org/10.1186/s12876-017-0676-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5701370/
https://www.ncbi.nlm.nih.gov/pubmed/29169329
http://dx.doi.org/10.1186/s12876-017-0676-8

Ejemplares similares